Clinical Trial Update: Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab [Phase 2]

View source ↗

Summary

Phase 2 trial comparing lapatinib plus vinorelbine versus vinorelbine alone in HER2-positive metastatic breast cancer patients who progressed after lapatinib/tr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Tykerb (lapatinib)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN